Axelsen Lene Nygaard, Haugan Ketil, Stahlhut Martin, Kjølbye Anne-Louise, Hennan James K, Holstein-Rathlou Niels-Henrik, Petersen Jørgen Søberg, Nielsen Morten Schak
Zealand Pharma A/S, 2600, Glostrup, Denmark.
J Membr Biol. 2007 Mar;216(1):23-35. doi: 10.1007/s00232-007-9026-z. Epub 2007 Jun 14.
Much of our current knowledge about the physiological and pathophysiological role of gap junctions is based on experiments where coupling has been reduced by either chemical agents or genetic modification. This has brought evidence that gap junctions are important in many physiological processes. In a number of cases, gap junctions have been implicated in the initiation and progress of disease, and experimental uncoupling has been used to investigate the exact role of coupling. The inverse approach, i.e., to increase coupling, has become possible in recent years and represents a new way of testing the role of gap junctions. The aim of this review is to summarize the current knowledge obtained with agents that selectively increase gap junctional intercellular coupling. Two approaches will be reviewed: increasing coupling by the use of antiarrhythmic peptide and its synthetic analogs and by interfering with the gating of gap junctional channels.
我们目前关于缝隙连接的生理和病理生理作用的许多知识都基于这样的实验,即通过化学试剂或基因改造来降低细胞间耦联。这已证明缝隙连接在许多生理过程中很重要。在许多情况下,缝隙连接与疾病的发生和发展有关,并且实验性解耦联已被用于研究耦联的确切作用。近年来,相反的方法,即增加耦联,已成为可能,并且代表了一种测试缝隙连接作用的新方法。这篇综述的目的是总结目前使用选择性增加缝隙连接细胞间耦联的试剂所获得的知识。将综述两种方法:通过使用抗心律失常肽及其合成类似物以及通过干扰缝隙连接通道的门控来增加耦联。